未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months接种灭活SARS-CoV-2疫苗TURKOVAC可诱导持续长达8个月的体液和细胞免疫应答。
Yilmaz, Secil; Eken, Ahmet; Sezer, Zafer; Bagci, Burcu Sen; Erdem, Serife; Sarikaya, Medine Dogan; Kaplan, Busra; Inal, Ahmet; Bayram, Adnan; Unuvar, Gamze Kalin; Zararsiz, Gokmen; Yerlitas, Serra Ilayda; Cakir, Nuri; Pavel, Shaikh Terkis Islam; Uygut, Muhammet Ali; Yetiskin, Hazel; Kara, Ates; Ozdarendeli, Aykut 分享 收藏 Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants针对祖先菌株 (ERAGEM)，Delta和Omicron变体的灭活二价SARS-CoV-2疫苗的功效Kaplan, Busra; Pavel, Shaikh Terkis Islam; Uygut, Muhammet Ali; Tunc, Merve; Eroksuz, Yesari; Celik, Ilhami; Eren, Esma Eryilmaz; Korukluoglu, Gulay; Kara, Ates; Ozdarendeli, Aykut; Yetiskin, Hazel 分享 收藏 The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccines既往SARS-CoV-2感染对接种TURKOVAC或CoronaVac灭活新型冠状病毒肺炎疫苗个体的疫苗后不良事件的影响Tanriover, Mine Durusu; Aydin, Ozlem Altuntas; Guner, Rahmet; Yildiz, Orhan; Celik, Ilhami; Kose, Sukran; Akhan, Sila; Akalin, Emin Halis; Ozdarendeli, Aykut; Unal, Serhat; Ates, Ihsan; Kara, Ates 分享 收藏 Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-UpSezer, Zafer; Pavel, Shaikh Terkis Islam; Inal, Ahmet; Yetiskin, Hazel; Kaplan, Busra; Uygut, Muhammet Ali; Aslan, Ahmet Furkan; Bayram, Adnan; Mazicioglu, Mumtaz; Unuvar, Gamze Kalin; Yuce, Zeynep Ture; Aydin, Gunsu; Kaya, Refika Kamuran; Ates, Ihsan; Kara, Ates; Ozdarendeli, Aykut 分享 收藏 SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variantsMamedov, Tarlan; Yuksel, Damla; Gurbuzaslan, Irem; Gulec, Burcu; Mammadova, Gulshan; Ozdarendeli, Aykut; Pavel, Shaikh Terkis Islam; Yetiskin, Hazel; Kaplan, Busra; Uygut, Muhammet Ali; Hasanova, Gulnara 分享 收藏 分享 收藏 Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variantsMamedov, Tarlan; Yuksel, Damla; Gurbuzaslan, Irem; Ilgin, Merve; Gulec, Burcu; Mammadova, Gulshan; Ozdarendeli, Aykut; Pavel, Shaikh Terkis Islam; Yetiskin, Hazel; Kaplan, Busra; Uygut, Muhammet Ali; Hasanova, Gulnara 分享 收藏 Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical StudyAtes, Ihsan; Batirel, Ayse; Aydin, Mehtap; Karadag, Fatma Yilmaz; Erden, Abdulsamet; Kucuksahin, Orhan; Armagan, Berkan; Guven, Serdar Can; Karakas, Ozlem; Gokdemir, Selim; Altunal, Lutfiye Nilsun; Buber, Aslihan Ayse; Gemcioglu, Emin; Zengin, Oguzhan; Inan, Osman; Sahiner, Enes Seyda; Korukluoglu, Gulay; Sezer, Zafer; Ozdarendeli, Aykut; Omma, Ahmet; Kara, Ates 分享 收藏 A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™)Gul, Fethi; Gonen, Zeynep Burcin; Jones, Olcay Y.; Tasli, Neslihan Pakize; Zararsiz, Gokmen; Unal, Ekrem; Ozdarendeli, Aykut; Sahin, Fikrettin; Eken, Ahmet; Yilmaz, Semih; Karakukcu, Musa; Kirbas, Oguz Kaan; Gokdemir, Nur Seda; Bozkurt, Batuhan Turhan; Ozkul, Yusuf; Oktay, Burcin Doruk; Uygut, Muhammet Ali; Cinel, Ismail; Cetin, Mustafa 分享 收藏 Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III TrialTanriover, Mine Durusu; Aydin, Ozlem Altuntas; Guner, Rahmet; Yildiz, Orhan; Celik, Ilhami; Doganay, Hamdi Levent; Kose, Sukran; Akhan, Sila; Akalin, Emin Halis; Sezer, Zafer; Ozdarendeli, Aykut; Unal, Serhat 分享 收藏 Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Turkey: A randomized trialOmma, Ahmet; Batirel, Ayse; Aydin, Mehtap; Karadag, Fatma Yilmaz; Erden, Abdulsamet; Kucuksahin, Orhan; Armagan, Berkan; Guven, Serdar Can; Karakas, Ozlem; Gokdemir, Selim; Altunal, Lutfiye Nilsun; Buber, Aslihan Ayse; Gemcioglu, Emin; Zengin, Oguzhan; Inan, Osman; Sahiner, Enes Seyda; Korukluoglu, Gulay; Sezer, Zafer; Ozdarendeli, Aykut; Kara, Ates; Ates, Ihsan 分享 收藏 Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2Tasli, Neslihan Pakize; Gonen, Zeynep Burcin; Kirbas, Oguz Kaan; Gokdemir, Nur Seda; Bozkurt, Batuhan Turhan; Bayrakci, Buse; Sagrac, Derya; Taskan, Ezgi; Demir, Sevda; Gurcan, Nur Ekimci; Bilgic, Melike Bayindir; Bayrak, Omer Faruk; Yetiskin, Hazel; Kaplan, Busra; Pavel, Shaikh Terkis Islam; Dinc, Gokcen; Serhatli, Muge; Cakirca, Gamze; Eken, Ahmet; Aslan, Vedat; Yay, Mehmet; Karakukcu, Musa; Unal, Ekrem; Gul, Fethi; Basaran, Kemal Erdem; Ozkul, Yusuf; Sahin, Fikrettin; Jones, Olcay Y.; Tekin, Saban; Ozdarendeli, Aykut; Cetin, Mustafa 分享 收藏 分享 收藏 Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19Mamedov, Tarlan; Yuksel, Damla; Ilgin, Merve; Guerbuezaslan, Irem; Gulec, Burcu; Mammadova, Gulshan; Ozdarendeli, Aykut; Yetiskin, Hazel; Kaplan, Busra; Islam Pavel, Shaikh Terkis; Uygut, Muhammet Ali; Hasanova, Gulnara 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
